.jpg)
레켐비의 가장 흔한 이상반응은
대부분 경증-중등증의 IRR, ARIA-H,
ARIA-E 및 두통이었으며, ARIA의 경우
대부분이 무증상이었습니다.
3,14
References. 3. Leqembi Korea Product Information. 24.11.15. 14. van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer’s disease. N Engl J Med. 2023;388(1):9-21. 25. Cmelak AJ, Lordick F, Borner M, Goldberg RM, Saif MW. Management of infusion reactions in clinical trials and beyond: the US and EU perspectives. Oncology (Williston Park). 2009;23(2 Suppl 1):18-25. 26. Sperling RA, Jack CR Jr, Black SE, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement. 2011;7(4):367-385.
.jpg)
.jpg)
References. 3. Leqembi Korea Product Information. 24.11.15. 14. van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer’s disease. N Engl J Med. 2023;388(1):9-21. 25. Cmelak AJ, Lordick F, Borner M, Goldberg RM, Saif MW. Management of infusion reactions in clinical trials and beyond: the US and EU perspectives. Oncology (Williston Park). 2009;23(2 Suppl 1):18-25. 26. Sperling RA, Jack CR Jr, Black SE, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement. 2011;7(4):367-385.
References. 3. Leqembi Korea Product Information. 24.11.15. 14. van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer’s disease. N Engl J Med. 2023;388(1):9-21. 25. Cmelak AJ, Lordick F, Borner M, Goldberg RM, Saif MW. Management of infusion reactions in clinical trials and beyond: the US and EU perspectives. Oncology (Williston Park). 2009;23(2 Suppl 1):18-25. 26. Sperling RA, Jack CR Jr, Black SE, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement. 2011;7(4):367-385.
레켐비의 가장 흔한 이상반응은
대부분 경증-중등증의 IRR, ARIA-H, ARIA-E 및 두통이었으며, ARIA의 경우
대부분이 무증상이었습니다.
3,14